
Ensign Peak Advisors’s Nuvation Bio NUVB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-63,763
| Closed | -$96.3K | – | 1743 |
|
2023
Q4 | $96.3K | Hold |
63,763
| – | – | ﹤0.01% | 1730 |
|
2023
Q3 | $85.4K | Hold |
63,763
| – | – | ﹤0.01% | 1742 |
|
2023
Q2 | $115K | Sell |
63,763
-175,568
| -73% | -$316K | ﹤0.01% | 1746 |
|
2023
Q1 | $397K | Buy |
239,331
+3,206
| +1% | +$5.32K | ﹤0.01% | 1679 |
|
2022
Q4 | $453K | Buy |
236,125
+10,712
| +5% | +$20.6K | ﹤0.01% | 1642 |
|
2022
Q3 | $505K | Sell |
225,413
-15,333
| -6% | -$34.4K | ﹤0.01% | 1445 |
|
2022
Q2 | $780K | Sell |
240,746
-782,739
| -76% | -$2.54M | ﹤0.01% | 1251 |
|
2022
Q1 | $5.39M | Sell |
1,023,485
-134,385
| -12% | -$707K | 0.01% | 570 |
|
2021
Q4 | $9.84M | Sell |
1,157,870
-65,110
| -5% | -$553K | 0.02% | 481 |
|
2021
Q3 | $12.2M | Buy |
1,222,980
+35,428
| +3% | +$352K | 0.03% | 398 |
|
2021
Q2 | $11.1M | Buy |
1,187,552
+338,888
| +40% | +$3.16M | 0.02% | 409 |
|
2021
Q1 | $8.87M | Buy |
848,664
+500,000
| +143% | +$5.22M | 0.02% | 453 |
|
2020
Q4 | $4.08M | Buy |
+348,664
| New | +$4.08M | 0.01% | 689 |
|